ArticleBritish journal of haematology2018

The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.

Christopher D Gocke et al.PubMed ↗Publisher ↗

No numbers read from the abstract.